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Severe burn injury renders patients susceptible to multiple infection episodes; however, 
identifying specific patient groups at high risk remains challenging. Burn-induced inflam-
matory response dramatically modifies the levels of various cytokines. Whether these 
changes could predict susceptibility to infections remains unknown. The aim of this 
study was to determine the early changes in the pro- to anti-inflammatory cytokine ratio 
and investigate its ability to predict susceptibility to repeated infections after severe burn 
trauma. The patient population consisted of 34 adult patients having early (≤48 h since 
injury) blood draws following severe (≥20% total burn surface area (TBSA)) burn injury 
and suffering from a first infection episode at least 1 day after blood collection. Plasma 
TNF-α and IL-10 levels were measured to explore the association between the TNF-α/
IL-10 ratio, hypersusceptibility to infections, burn size (TBSA), and common severity 
scores (Acute Physiology and Chronic Health Evaluation II (APACHEII), Baux, modified 
Baux (R-Baux), Ryan Score, and Abbreviated Burn Severity Index (ABSI)). TNF-α/IL10 
plasma ratio measured shortly after burn trauma was inversely correlated with burn size 
and the injury severity scores investigated, and was predictive of repeated infections (≥3 
infection episodes) outcome (AUROC [95%CI] of 0.80 [0.63–0.93]). Early measures of 
circulating TNF-α/IL10 ratio may be a previously unidentified biomarker associated with 
burn injury severity and predictive of the risk of hypersusceptibility to repeated infections.
Keywords: burns, injuries, biomarkers, infection, cytokines, burn severity, immune response, burn trauma
inTrODUcTiOn
Burn injury, one of the major causes of trauma-related mortality worldwide, is a significant global 
public health concern (1). While the majority of burn patients no longer die directly from the shock 
induced by the burn trauma as a result of advances in modern resuscitation measures, infections 
and infection-related complications developed days after admission continue to pose significant 
risks to patients’ lives (2). Considering this negative impact of burn-related infections on mortal-
ity, patient recovery, and health-care costs, it is crucial to develop novel methods to detect and 
manage specific patients with increased risk of infection (3). Furthermore, the pervasiveness of 
indiscreet antimicrobial use in the clinics contributes to toxicity in patients and the rapid emergence 
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of multidrug-resistant strains (4). Improved methods to identify 
patients most at risk of repeated infection episodes at triage have 
the potential to facilitate personalization of prophylactic anti-
infection therapies and enhance antibiotic stewardship (5).
Severe burn trauma contributes to the pathogenesis of infec-
tions and infection-related morbidity by various direct dermal 
and non-dermal factors (6). There is ample evidence demon-
strating that trauma-related factors of burn size [percent of total 
burn surface area (TBSA)] and smoke inhalation injury result 
in increased risk of death (7–10) and that the elimination of the 
dermal barrier renders extensively burned patients susceptible to 
bacterial, fungal, and viral infections (11). Burn extent was also 
previously found to correlate with increased gut permeability, 
which may be a non-dermal factor leading to altered immune 
response and infection-related outcomes (12). Severity scores 
have been developed for the early assessment of the risk of mor-
tality for burn patients, including the Ryan Score (7), Abbreviated 
Burn Severity Index (ABSI) (13), Baux Score (14), and modified 
Baux (R-Baux) Score (9). The Acute Physiology and Chronic 
Health Evaluation (APACHEII) score is also a measure of injury 
severity that is generally applied to all adult Intensive Care Unit 
(ICU) patients (15). Previous studies have evaluated the use of 
these various clinical severity scores in assessing risk of infection 
(16–18). These scores require multiple clinical measurements and 
are not applied specifically for infection prediction. Therefore, it is 
of interest to develop early biomarkers that may further improve 
the identification of the subset of patients at risk of infection 
and related outcomes among a population of extensively burned 
patients, who are especially susceptible.
The effects of burn trauma at the molecular level and bio-
marker development have only been explored in limited depth. 
Recently, we identified a leukocyte transcriptome biomarker 
panel that could predict hypersusceptibility to infections in burn 
patients (19). Hypersusceptible patients showed early alterations 
in immune-related signaling pathways, epigenetic modulation, 
and chromatin remodeling. Considering the pivotal role of the 
immune response following burn trauma, the ability to predict 
adverse outcomes based on an early blood biomarker is expected 
to contribute significantly to the implementation of personalized 
management of burn patients and the use of risk stratification (3).
It is well established that major burn injuries induce acute 
systemic and localized activation of inflammatory pathways, 
leading to the release of various cytokines (20–23). These studies 
suggested that proinflammatory biomarkers, including tumor 
necrosis factor-α (TNF-α), C-reactive protein (CPR), and inter-
leukin-6 (IL-6), may be useful for monitoring post-burn inflam-
mation and/or immune dysfunction. A previous study found 
IL-4, IL-8, granulocyte macrophage colony-stimulating factor 
(GM-CSF), and monocyte chemotactic protein 1 (MCP-1) to be 
predictive of death from sepsis and multiple organ failure (MOF) 
(22). Another study among burn patients found an association of 
IL-8 levels with sepsis, MOF, and increased length of stay (24). 
Moreover, severely burned non-survivor children with inhalation 
injury displayed increased IL-4, IL-7, IL-10, and IL-13 levels at 
admission compared to survivors (25). IL-1RA, IL-6, and MCP-1 
were also found to be predictive of mortality following severe 
burns (26). Although these studies found associations of altered 
cytokine levels with mortality and morbidity after burn trauma, 
no previous studies have investigated whether circulating blood 
cytokine biomarkers soon after injury could identify specific 
patients who are hypersusceptible to increased infection episodes 
during the course of recovery.
We specifically investigated the role of early plasma TNF-α and 
IL-10 as predictors of hypersusceptibility to infections after burn. 
TNF-α is a major proinflammatory cytokine indispensable for 
microbial infection control, and IL-10 is a crucial anti- inflammatory 
cytokine that is additionally known to negatively regulate TNF-α 
signaling (27, 28). Thus, it is conceivable that the balance or ratio 
between these cytokines may serve as a surrogate measure of 
pro- to anti-inflammatory immune homeostasis. Moreover, we 
hypothesized that assessing the ratio of TNF-α and IL-10 would 
aid in overcoming the challenges of inter- and intra-individual 
variability in leukocyte number, which is expected to make 
normalization of secreted plasma cytokine levels difficult (29).
The TNF-α/IL-10 ratio has been previously used as a biomarker 
in a few cohort studies. In a study conducted in Russia among 
healthy children and children with cystic fibrosis, live rubella 
vaccine challenge attenuated TNF-α/IL-10 ratio (30). Another 
study among North Indian adults found it to be elevated in the 
plasma of acute myocardial infarction patients compared to that 
of matched healthy control (31). An additional study conducted 
in Brazil found TNF-α/IL-10 ratio to be correlated with hypergly-
cemia in the plasma and placenta of pregnant women (32). While 
these studies demonstrate the use of the TNF-α/IL-10 ratio as a 
biomarker, it has yet to be assessed in the context of trauma and 
infection prediction.
This study aims to evaluate whether the TNF-α/IL-10 ratio, 
a cytokine marker of the balance between key pro- to anti-
inflammatory levels, would predict susceptibility to multiple 
infections. Predicting the risk before the occurrence of infection 
has the potential to maximize the valuable window of time for 
early interventions for preventing or minimizing infections. The 
use of precision medicine that is linked to the use of genomic and 
transcriptome data will permit the early triage of patients and 
early assessment of their risk to multiple infections. Thus, it would 
enable the integration of predictive analytics into high-value 
care, as optimized treatment courses and personalized precision 
therapy will be delivered, in addition to antibiotic stewardship 
and care cost reduction.
MaTerials anD MeThODs
study Design/Patient and Outcome 
Definition
This study was performed by means of the secondary use of 
573 patient clinical data from the Inflammation and the Host 
Response to Injury Study (“Glue Grant”), a prospective, longi-
tudinal study which enrolled burn patients with minimum 20% 
TBSA at six US institutions between 2003 and 2009. Permission 
for this secondary use of the de-identified data was obtained from 
the Massachusetts General Hospital Institutional Review Board.
Among the 573 patients in the database we used, 81 had blood 
samples with plasma proteomic information available. From 
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these 81 patients, a total of 34 adult (age ≥16  years) patients 
were analyzed based on our inclusion criteria of having not 
sustained electrical burn injury, with early (≤48 h since injury) 
blood sample collection, had first infection found not sooner 
than 24 h after blood draw, spent at least 1 day in the ICU, and 
had clinical data available. Where patients had more than one 
blood sample collection, the earliest collection was used for the 
analysis. Forty-six individuals were excluded for one or more of 
the following reasons: 31 were pediatric patients aged ≤16 years; 
1 patient suffered from electrical burns; thus, TBSA values were 
considered to be not representative of the severity of their burn 
injury; 31 had first blood sample >48  h; 36 had first recorded 
infection prior to, or less than a day after first blood collection; 
and thus, it was considered that cytokine expression may not be 
predictive of but potentially a consequence of infection (Figures 
S1 and S2 in Supplementary Material).
The definitions of clinical outcomes are based on the guide-
lines outlined by the GLUE Grant Consortium that participating 
institutions followed (Materials and Methods in Supplementary 
Material). Total infection episode counts from the time of the 
injury were tabulated similarly to the method described in a 
previous publication, based on a decision tree that takes into con-
sideration the timing of infections, type of infection, and type of 
pathogen isolated (19). Briefly, in order to determine whether or 
not a subsequent episode was independent (i.e., not an extension 
of a previously recorded infection), each record was considered 
to be on a “waiting list” for 6  days if the types and modes of 
infection and pathogen were similar or 2 days if they were not. In 
this study, the case hypersusceptible group was defined as those 
having experienced repeated infections (≥3 cumulative infection 
episodes). According to this definition of hypersusceptibility, half 
of the patients (14 patients) were classified as the case group.
Blood sample collection and processing methods for cytokine 
levels of the Glue Grant cohort was previously described (21, 22, 
24). In short, peripheral blood was collected before anesthesia 
induction in preparation of operational intervention and pro-
cessed within 1 h of blood draw by centrifugation at 400 × g at 
22°C for 10 min for plasma isolation. These samples were stored 
at −80°C at the Inflammation and the Host Response to Injury 
Sample Collection and Coordination Site at the University of 
Florida College of Medicine, Gainesville, FL, USA. Plasma 
cytokine concentrations were quantified by the Linco Research 
multiplex bead array and MiraiBio software for analysis (24). For 
this study, the TNF-α/IL-10 ratio was calculated from picograms 
per milliliter of cytokine levels recorded for TNF-α and IL-10 for 
each patient.
The APACHEII Score (15) was recorded at the respective 
participating institutions. For this study, the Ryan Score (7) was 
assigned as previously described, where patients received a Ryan 
Score of 1 for each of the following risk factors – TBSA percent 
above 40, age above 60, and the presence of inhalation injury. 
ABSI was calculated by adding 1 point for male and 0 for female, 
adding 1 point for the presence of inhalation injury and 0 with-
out, adding 1 point for the presence of third-degree burns and 0 
without, and adding allocated points for each ABSI age category 
(1 point for 0–20 years, 2 points for 21–40 years, and so forth 
at 20-year intervals) and TBSA categories (1 point for 1–10%, 2 
points for 11–20%, and so forth at 10% intervals) (13). The classic 
Baux Score was determined by summing the TBSA percent (14) 
and age. The Modified Baux (R-Baux) Score was calculated by 
adding the TBSA and age for patients without inhalation injury 
presence or an additional 17 for those with inhalation injury (9).
statistical analysis
Baseline characteristics for the overall study population and for 
those stratified into hypersusceptible case (≥3 infection episode) 
and non-case (≤2 infection episode) groups are reported as 
means with SDs, medians with interquartile range, or proportions 
and percentages, as indicated in the legend. For comparing means 
between two groups, the two-sample equal variance t-test with 
two-tailed p-values was used, and for comparing means across 
more than one group, the one-way analysis of variance (ANOVA) 
was used, with Dunnett’s post  hoc test. Medians between two 
groups were compared by using the Mann–Whitney test with 
two-tailed p-value. For comparing proportions, Fisher’s exact 
test with two-tailed p-values was used to account for the small 
sample size.
Logistic regression models were fitted by Firth’s penalized 
maximum likelihood method using the “logistf ” package in R 
(33) to account for the small sample size of our study (34) for 
evaluating the association of the continuous predictors of TNF-α/
IL-10, TBSA, APACHEII Score, Baux Score, and R-Baux, with 
the outcome of susceptibility to infection events (≥3 cumulative 
infection episodes). The 95% confidence intervals for the total 
area under receiver operating characteristic curve (AUROC) was 
constructed by stratified bootstrap with 10,000 replicates with 
replacement using the “pROC” package in R (35). Sensitivity and 
specificity 95% confidence intervals were calculated according to 
the Wilson score method with continuity correction (36).
software Used
SAS 9.3 (SAS Institute Inc., NC, USA) and R3.1.3 were used for 
the analyses described above.
resUlTs
Patient Demographics and Baseline 
characteristics
The characteristics of the 34 adult subjects included in the study 
are presented in Table 1 and Figure S1 in Supplementary Material. 
The overall study population consisted of approximately two-
third males (64.7%), with an average ±SD age of 40.6 ± 17.2 years 
(Table 1). Our study is comprised of extensively burned patients, 
with patients suffering from a mean TBSA of 41.6 ± 18.8% with the 
great majority presenting with third-degree burns (91.2%). Forty-
four percent had sustained inhalation injury, and the majority of 
burn injury was due to flame (67.7%). A high proportion of the 
patients developed infections, with the median [IQR] number 
of infection episodes of 3 [1–6], with 52.9% of patients having 
had recorded burn wound site infections and 82.4% with various 
types of nosocomial infections. The prevalence of the different 
subtypes of nosocomial infections recorded included 55.9% with 
pneumonia, 38.2% bloodstream infections, 44.1% with urinary 
TaBle 1 | Baseline characteristics, where results are shown.
all patients  
(N = 34)
non-cases: ≤2 infection  
episode (N = 17)
Mie cases: ≥3 infection  
episodes (N = 17)
p-value
(1) Demographics
Age (years)a 40.6 ± 17.2 38.4 ± 16.5 42.8 ± 18.2 0.464
Sex (male)c 22 (64.7%) 12 (70.6%) 10 (58.9%) 0.721
BMI, continuous (kg/m2)a 26.3 ± 6.9 26.7 ± 6.0 25.9 ± 7.9 0.765
Time since injury before admission (h)a 4.1 ± 2.5 3.9 ± 2.7 4.4 ± 2.3 0.513
(2) Characteristics/severity of burn injuryc 0.364
Etiology: flame 23 (67.7%) 10 (58.8%) 13 (76.5%) 0.465
Flash 5 (14.7%) 2 (11.8%) 3 (17.7%) 1.000
Scald 2 (5.9%) 2 (11.8%) 0 (0%) 0.485
Other 4 (11.8%) 3 (17.7%) 1 (5.9%) 0.601
TBSA (%)a 41.6 ± 18.8 31.9 ± 11.2 51.2 ± 20.0 0.0015
Second-degree burn (yes)c 27 (79.4%) 13 (76.5%) 14 (82.4%) 1.000
Third-degree burn (yes)c 31 (91.2%) 14 (82.4%) 17 (100%) 0.227
Inhalation injury (yes)c 15 (44.1%) 5 (29.4%) 10 (58.8%) 0.166
APACHEIIa 19.0 ± 8.2 14.1 ± 7.8 23.8 ± 5.2 0.0003
Bauxa 82.1 ± 23.9 70.3 ± 13.7 94.0 ± 26.2 0.0002
R-Bauxa 89.6 ± 26.4 75.3 ± 16.1 104.0 ± 27.1 0.0007
Ryan Scoreb 1 [0–2] 1 [0–1] 1 [1–2] 0.0022
Abbreviated Burn Severity Index (ABSI)b 9 [7–11] 7 [7–9] 11 [9–11] 0.0005
(3) Plasma collection
First blood collection since injury (h)a 19.9 ± 12.0 20.4 ± 12.0 19.3 ± 12.4 0.796
TNF-α/IL-10 ratioa 0.134 ± 0.136 0.200 ± 0.154 0.067 ± 0.072 0.0029
(4) Infections-related outcomes
First infection day since injuryd (days)a 5.4 ± 3.0 5.8 ± 3.6 5.2 ± 2.7 0.573
Number of infection eventsb 3 [1–6] 1 [0–2] 6 [5–10] <0.0001
Burn wound infection (yes)c 18 (52.9%) 3 (17.6%) 15 (88.2%) <0.0001
Nosocomial infectione (yes)c 28 (82.4%) 12 (70.6%) 16 (94.1%) 0.175
Pneumonia (yes)c 19 (55.9%) 5 (29.4%) 14 (82.4%) <0.0001
Bloodstream infection (yes)c 13 (38.2%) 1 (5.9%) 12 (85.7%) 0.0002
Urinary tract infection (yes)c 15 (44.1%) 5 (29.4%) 10 (58.8%) 0.166
Endocarditis (yes)c 1 (2.9%) 0 (0%) 1 (100%) 1.000
Pseudomembranous colitis (yes)c 2 (5.9%) 0 (0%) 2 (100%) 0.485
Catheter-related bloodstream infection (yes)c 6 (17.6%) 1 (5.9%) 5 (29.4%) 0.175
Other (yes)c 7 (20.6%) 2 (11.8%) 5 (29.4%) 0.398
(5) Outcomes
Death (yes)c 6 (17.6%) 1 (5.9%) 5 (29.4%) 0.175
Hospital stay lengthf (days)a 55.0 ± 53.4 27.2 ± 15.4 92.2 ± 63.7 0.0005
aMean ± SD with t-test two-tailed p-values.
bMedian [IQR] with Mann–Whitney two-tailed p-values.
cNumber of patients (%) with Fisher’s exact two-tailed p-values.
dAmong those with at least one recorded infection.
eNosocomial infections exclude burn wound infections and include the subcategory recording described below it.
fAmong survivors (n = 28).
4
Tsurumi et al. TNF-α/IL-10 as a Predictive Tool for Infections
Frontiers in Public Health | www.frontiersin.org October 2016 | Volume 4 | Article 216
tract infection, 2.9% endocarditis, 5.9% pseudomembranous coli-
tis, and 17.6% catheter-related bloodstream infections. Various 
clinical severity scores were calculated. Overall, patients had 
mean general APACHEII Severity Score of 19.0 ± 8.2 and burn-
specific severity scores of 82.1 ± 23.9 Baux Score and 89.6 ± 26.4 
R-Baux Score (Table 1). For the categorical severity scores, the 
patients had median [IQR] Ryan Score of 1 [0–2] and ABSI of 
9 [7–11]. Patients arrived at the hospital soon after injury, with 
average arrival time of 4.1 ± 2.5 h since injury and average blood 
collection time of 19.9 ± 12.0 h since injury. The average TNF-α/
IL-10 cytokine ratio was 0.134 ± 0.136, and average time to first 
recorded infection was 5.4 ± 3.0 days post-burn. The risk of death 
overall was 17.6%, and the average length of hospital stay was 
55.0 ± 53.4 days among survivors.
Demographic characteristics, including age, sex, BMI, 
mechanisms of injury, were not significantly different between 
hypersusceptible and control patients (Table 1). On the other 
hand, hypersusceptible patients had significantly higher meas-
ures of injury severity, including TBSA (mean 31.9 ±  11.2% 
for non-cases versus 51.2  ±  20.0% for cases, p  =  0.0015), 
APACHEII score (mean 14.1  ±  7.8 for non-cases versus 
23.8 ±  5.2 for cases, p =  0.0003), Baux (mean 70.3 ±  13.7 
for non-cases versus 94.0 ± 26.2 for cases, p = 0.0002), R-Baux 
(mean 75.3 ± 16.1 for non-cases versus 104.0 ± 27.1 for cases, 
p = 0.0007), Ryan Score (median 1 [1–0] for non-cases versus 1 
[1–2] for cases, p = 0.0022), and ABSI (median 7 [7–9] for non-
cases versus 11 [9–11] for cases, p = 0.0005). Although there 
was slightly increased proportion of patients having suffered 
third-degree burns among the case group, it is not significant 
(82.4% for non-cases versus 100% for cases, p  =  0.227), 
presumably due to the high overall prevalence among our 
particular severely injured patient group. The prevalence of 
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inhalation injury was higher in the hypersusceptible patients, 
although not significant (29.4% for non-cases versus 58.8% of 
cases, p =  0.166).
The biomarker of interest, plasma cytokine TNF-α/IL-10 
ratio, was significantly lower in the hypersusceptible patient 
group (mean 0.200 ± 0.154 for non-cases versus 0.067 ± 0.072 
for cases, p  =  0.0029), despite comparable hospital admis-
sion time (mean 3.9 ± 2.7 h since injury for non-cases versus 
4.4 ±  2.3  h since injury for cases, p =  0.513) and first blood 
collection time between the two groups (mean 20.4 ±  12.0  h 
since injury for non-cases versus 19.3 ± 12.4 h since injury for 
cases, p = 0.796). The first recorded infection times were also 
similar between the hypersusceptible and case groups (mean 
5.8 ±  3.6 days since injury for non-cases versus 5.2 ±  2.7 for 
cases, p = 0.573). Among survivors, days of stay in the hospital 
were significantly longer for patients with repeated infections 
(mean 27.2 ± 15.4 for non-cases versus 92.2 ± 63.7 for cases, 
p = 0.0005), as expected.
Burn injury severity is inversely correlated 
with TnF-α/il-10 cytokine ratio
In order to determine the correlation between the severities of 
burn injury to the levels of early pro- versus anti-inflammatory 
state as ascertained by the early plasma TNF-α/IL-10 ratio, we 
first stratified patients according to mean TBSA, inhalation 
injury, and full-thickness burn status. Patients below the mean 
TBSA (≤41%) had average ±SD early TNF-α/IL-10 ratio level of 
0.178 ± 0.150, compared to more extensively burned patients with 
above mean TBSA (≥42%) that had 0.052 ± 0.042 (p = 0.0076) 
(Figure 1A). Stratifying patients into categories according to the 
first quartile, median, and third quartile TBSA also showed a 
progressive decrease in TNF-α/IL-10 ratio, from 0.206 ± 0.142 
to 0.179 ± 0.193 to 0.1012 ± 0.07 to 0.0439 ± 0.04 (p < 0.05 from 
below the first quartile to above the third quartile) (Figure S3A 
in Supplementary Material). Those who did not suffer inhalation 
injury had mean 0.175 ± 0.159 TNF-α/IL-10 cytokine ratio, com-
pared to those who did, who had mean TNF-α/IL-10 cytokine 
ratio of 0.082 ±  0.078 (p =  0.0462) (Figure  1B). The majority 
of patients in our dataset had full-thickness burn; however, 
compared to those without, whose mean TNF-α/IL-10 cytokine 
ratio was 0.286 ±  0.177, those who had suffered full-thickness 
burns had mean TNF-α/IL-10 cytokine ratio of 0.119 ±  0.126 
(p  =  0.0407) (Figure  1C). Together, these data indicate that 
individual measures of burn injury correlates with early TNF-α/
IL-10 cytokine ratio.
We then compared patients according to the continuous 
injury severity scores of the general APACHEII score and 
burn-specific Baux and R-Baux scores. Patients who had 
APACHEII score below the mean (≤18) had mean TNF-α/
IL-10 cytokine ratio of 0.206 ±  0.156, compared to patients 
with above mean (≥19) APACHEII who had mean TNF-α/
IL-10 cytokine ratio of 0.061 ± 0.055 (p = 0.001) (Figure 1D). 
When stratifying patients according to quartile categories of 
APACHEII, the TNF-α/IL-10 cytokine ratio decreased progres-
sively, from 0.238 ±  0.176 to 0.171 ±  0.132 to 0.070 ±  0.055 
to 0.049 ±  0.055 (p <  0.05 from below the first quartile to 
between the median and third quartile, and p  <  0.01 from 
below the first quartile to above the third quartile) (Figure S3B 
in Supplementary Material). The group of patients with below 
mean Baux Score (≤82) had mean TNF-α/IL-10 cytokine ratio 
of 0.176 ± 0.147 compared to patients with above mean (≥83) 
Baux of 0.0734  ±  0.094 (p  =  0.0286) (Figure  1E). Patients 
with below mean R-Baux Score (≤89) had mean TNF-α/IL-10 
cytokine ratio of 0.194 ± 0.152 compared to patients with above 
mean (≥90) R-Baux of 0.0735 ± 0.088 (p = 0.0079) (Figure 1F).
Additionally, we evaluated patients across the categorical 
injury severity measures of the Ryan Score and ABSI. Our 
patient group’s Ryan Score varied from the lowest 0 to the 
maximum of 3. Each increase in Ryan Score resulted in pro-
gressive decrease in TNF-α/IL-10 cytokine ratio compared to 
the basal score of 0, of mean TNF-α/IL-10 cytokine ratio of 
0.243 ± 0.171 to Ryan Score 1 with mean TNF-α/IL-10 cytokine 
ratio of 0.107 ± 0.102 to Ryan Score 2 with mean TNF-α/IL-10 
cytokine ratio of 0.060  ±  0.023 to Ryan Score 3 with mean 
TNF-α/IL-10 cytokine ratio of 0.037 ± 0.010 (p < 0.05 from 0 
to 1, and from 0 to 2, and p <  0.1 from 0 to 3) (Figure  1G). 
For the ABSI score, the lowest corresponded to the category of 
“moderately severe” (ABSI score 6–7), to “serious” (ABSI score 
8–9), “severe” (ABSI score 10–11), and “maximum” (ABSI score 
≥12) severity. Categorizing patients according to increased 
ABSI severity category found decreased levels of mean TNF-α/
IL-10 cytokine ratio from the “moderately severe” category of 
0.212 ± 0.121 to the “serious” category of 0.179 ± 0.189 to the 
“severe” category of 0.0508 ± 0.055, and the “maximum” severity 
category of 0.057 ± 0.033 (p < 0.05 from “moderately severe” to 
“serious” and p < 0.1 from “moderately severe” to “maximum”) 
(Figure  1H). Collectively, these data demonstrate overall that 
mean TNF-α/IL-10 cytokine ratio is inversely correlated with 
the various burn injury severity measures described above and 
may reflect a state of immunosuppression.
early Plasma TnF-α/il-10 cytokine 
ratio Maybe a novel Biomarker to 
Predict increased risk to Multiple 
infection episodes
The baseline measure of TNF-α/IL-10 cytokine ratio of patients 
who were less susceptible to multiple infection episodes during 
the course of their recovery (≤2 total episodes) was 0.200 ± 0.154, 
significantly higher compared to hypersusceptible patients who 
experienced repeated infection episodes (≥3 total episodes), 
with mean TNF-α/IL-10 cytokine of 0.067 ± 0.072 (p = 0.0029) 
(Figure 2A). In order to assess whether or not early circulating 
plasma TNF-α/IL-10 ratio may indeed be a novel predictive 
biomarker for hypersusceptibility to infections, we assessed the 
AUROC of the various logistic models with TNF-α/IL-10, TBSA, 
and the various continuous severity scores (Figure 2B). Using 
TNF-α/IL-10 ratio as the sole predictor yielded an AUROC (95% 
CI) of 0.80 (0.63–0.93), similarly to TBSA of 0.80 (0.64–0.93), 
APACHEII of 0.86 (0.70–0.98), Baux of 0.80 (0.62–0.95), and 
R-Baux of 0.83 (0.67–0.95). Combining the various clinical with 
the TNF-α/IL-10 ratio resulted in AUROCs (95% CI) for TNF-α/
IL-10 + TBSA of 0.86 (0.71–0.97), TNF-α/IL-10 + APACHEII 
FigUre 1 | Various injury severity measures are inversely correlated to TnF-α/il10. (a) TBSA percent above the mean, (B) the presence of inhalation injury 
and (c) full-thickness burn, above mean (D) APACHEII Score, (e) Baux and (F) R-Baux, and each increasing (g) Ryan Score and (h) ABSI categories show 
significantly decreased TNF-α pro- to IL-10 anti-inflammatory plasma cytokine ratio for most (SE as error bars, t-test two-sided p-values indicated, or one-way 
ANOVA with Dunnett’s post hoc test, *p < 0.1 and **p < 0.05 compared to the first category).
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of 0.85 (0.70–0.98), TNF-α/IL-10 + Baux of 0.85 (0.70–0.97), 
and TNF-α/IL-10  +  R-Baux of 0.87 (0.74–0.97). The model 
with a single predictor of TNF-α/IL-10 and APACHEII and 
combined TNF-α/IL-10 +  R-Baux had the highest sensitivity 
(95% CI) without compromising specificity (95% CI), of each 
having 0.82 (0.56–0.95) for both sensitivity and specificity. 
Although the combined model of TNF-α/IL-10 + APACHEII 
had the highest sensitivity of 0.88 (0.62–0.98), its specificity was 
decreased, with 0.76 (0.50–0.92). The TNF-α/IL-10 + Baux had 
equally high sensitivity of 0.82 (0.56–0.95); however, the speci-
ficity was decreased to 0.71 (0.44–0.89). The single predictors 
of R-Baux had sensitivity and specificity of 0.76 (0.50–0.92) and 
Baux had equal sensitivity, however, higher specificity of 0.82 
(0.56–0.95). Although TBSA had the lowest sensitivity of 0.65 
(0.39–0.85), its specificity was among the highest of the models, 
with 0.82 (0.56–0.95).
FigUre 2 | TnF-α/il-10 protein ratio is inversely correlated with (a) susceptibility to infections and predictive of the outcome of repeated infections 
(≥3 infection episodes), as shown by the (B) total area under the rOc curve, sensitivity, and specificity of various logistic regression models.
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Various Microbes are Prevalent among 
severely Burned Patients
Various microbes tested were detected, with Enterococcus, 
coagulase-negative staphylococci and Staphylococcus aureus 
being among the highest prevalence among our overall patient 
population (50.0%, 47.1, and 44.1 respectively). Other microbes 
detected in descending order of prevalence, include Candida spe-
cies (35.3%), Pseudomonas aeruginosa (26.5%), Gram-positive 
NOS (26.5%), Gram-negative NOS (26.5%), Acinetobacter 
(23.5%), Escherichia coli (23.5%), Klebsiella pneumoniae (23.5%), 
Streptococcus viridans (20.6%), Fungi NOS (20.6%), Streptococcus 
pneumoniae (17.6%), Hemophilus influenza (14.7%), Entrobacter 
species (11.8%), unknown (8.8%), Aspergillus (5.9%), Clostridium 
species (5.9%), Stenotrophomonas (5.9%), and Proteus (2.9%) 
(Figure  3). In order to determine whether early TNF-α/IL-10 
level is associated with the risk of a patient later developing infec-
tion to specific pathogens, we sorted the patients according to 
their TNF-α/IL-10 ratio z-scores. Clusters of pathogens appeared 
to group according to the hypersusceptibility status rather than 
the TNF-α/IL-10-fold change levels, suggesting that it is likely 
a risk factor for repeated infections in general, rather than to 
specific pathogens. In some cases, patients with relatively lower 
clinical severity scores had relatively higher TNF-α/IL-10 levels 
and vice versa, as determined by the population z-score for each 
of the continuous severity scores, suggesting that an individual 
patient’s response to injury may also play a distinct role.
DiscUssiOn
Our study demonstrates that burn trauma severity is inversely 
correlated with early blood plasma pro- to anti-inflammatory 
signaling ratio, perhaps due to a state of immunosuppression that 
accompanies severe trauma. This finding is strengthened by our 
study design, in which we conducted our analyses using several 
different measures of injury severity. Although the cytokine ratio 
and the various severity scores were significantly inversely corre-
lated, in some selected patients, the measured TNF-α/IL-10 ratio 
was high, despite high injury severity measures and vice versa. 
This observation may argue for the possibility that TNF-α/IL-10 
is not merely a reflection of injury severity but also plays a distinct 
role in individuals’ response to injury and susceptibility to infec-
tions. Control samples of plasma from the base population prior 
to burn injury would enable our study to distinguish between 
these possibilities; however, such sample is impossible to obtain. 
It is also important to note that the current study base consists 
of a particularly critically ill patient population, who are severely 
(≥20% TBSA) burned with an overall high proportion having 
experienced inhalation injury and full-thickness burns.
It may also be informative to further investigate mechanistic 
aspects of cytokine regulation among burn patients, which is 
expected to be complex and likely mediated by various direct 
dermal and non-dermal processes. TBSA was previously found 
to correlate with increased gut permeability, which may be one 
FigUre 3 | clustering of the different types of microbes with hypersusceptibility status. The overall prevalence of each microbe is indicated in the 
parentheses in each microbe’s label. Dark gray filling indicates positive hypersusceptibility status and presence of specific microbes. TNF-α/IL-10 was sorted by the 
z-score of the population, and the corresponding severity score z-scores are shown in the columns as indicated.
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mechanism leading to altered immune response by non-dermal 
processes, and it would be of interest to assess the relationship 
between cytokine biomarkers and gut permeability (12). Moreover, 
it has been reported that insulin attenuates cytokine response in 
a burn wound infection model (37), and thus, perhaps further 
studies of the immune response upon severe burns in diabetic 
patients may also be informative. Studies using animal models 
of burn have found that inhalation injury impacts the systematic 
immune response, independently of burn injury (38, 39), and 
in human cohort studies, increased severity of inhalation injury 
was also correlated with cytokine induction (40, 41). Our current 
study that found TNF-α/IL10 cytokine ratio to be significantly 
lower in patients with inhalation injury supports such notion that 
the localized sustained trauma often experienced by burn patients 
may also contribute to the systemic cytokine response. It would 
therefore be beneficial to further dissect the precise mechanisms, 
resulting in systemic immunosuppression by burn injury.
In addition to establishing that TNF-α/IL-10 ratio is inversely 
correlated with burn injury severity measures of TBSA, inhala-
tion injury status, APACHEII, Baux, R-Baux, Ryan, and ABSI 
scores, we found that it is a biomarker that predicts increased risk 
of hypersusceptibility to infection during the course of recovery. 
Given the role of the systematic immune response in combating 
pathogenic encounters, our finding is mechanistically plausible. 
Moreover, our observations are strengthened by the use of early 
blood samples, prior to infections. Since the lack of fast and sensi-
tive pathogen detection methods in the current clinical setting 
impose complications on epidemiological studies of infection, in 
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our current study, we analyzed only patients whose time to first 
recorded infection was more than a day after the time of blood 
collection. Furthermore, the average time to first recorded infec-
tion among patients in our dataset was approximately 5 days since 
injury. Thus, given our study design, we expect that our results 
on the association of TNF-α/IL10 cytokine ratio are predictive 
of later infections, rather than a consequence of pathogenic 
encounter. Various pathogens were detected among patients, 
including species that are commonly antibiotic resistant and 
present a major threat to patients’ recovery process in the hospital 
setting, including ESKAPE pathogens, Enterococcus, S. aureus, 
K. pneumoniae, Acinetobacter baumannii, and P. aeruginosa. Our 
current study which analyzes the risk of patients’ susceptibility 
to repeated infections during recovery aims to contribute to 
enhanced methods of personalized medicine and antibiotic 
stewardship for limiting the inappropriate use of antibiotics.
Previous studies investigating cytokines following burn injury 
have mainly focused on each anti- or proinflammatory cytokine 
individually. A study among severely burned adult and pediatric 
populations plotted various average cytokine levels over time 
(21, 22). Moreover, a study found increased levels of certain 
cytokines at admission among patients who later died of sepsis, 
compared to patients who did not experience sepsis (20). Burn 
size categories were correlated with differential expression of 
several cytokines and organ function measures of cardiac output 
and liver size, among children (42). An additional study inves-
tigated the association of plasma IL-8 during the first 60  days, 
among severely burned patients in whether or not an infection 
was ever recorded, the occurrence of sepsis, MOF, and mortality, 
among pediatric patients (24). It is well established from animal 
and cell culture studies that anti- and proinflammatory cytokines 
are coregulated and interdependent and that burn trauma leads 
to increased differentiation and accumulation of leukocytes (43). 
Thus, the secreted cytokine level in plasma may differ between 
individuals based on innate variability of leukocyte numbers 
as a consequence of the severity of injury. Our current study 
overcomes this variability by our approach of assessing the 
relative pro- to anti-inflammatory cytokine ratio to allow for 
normalization, thereby negating observed differences between 
individuals, which is potentially a reflection of mere leukocyte 
number. Moreover, severe clinical outcomes, such as death and 
MOF, may be a consequence of various complications, and our 
study focusing on a well-defined, distinct outcome of repeated 
infections (≥3 infection episodes) is unparalleled.
Studies of TNF-α/IL-10 ratio in humans found that this ratio 
is attenuated following live rubella vaccine challenge among 
children (30), is elevated in the plasma of acute myocardial 
infarction patients compared to matched healthy control (31), 
and is associated with hyperglycemic states in placental tissues, 
with type 2 diabetes mellitus patients having the highest level 
(32). However, our unique approach of investigating infections 
by our recently defined method of quantifying cumulative 
infection episodes (19), prior to first recorded infection as an 
improved method, provides additional insight on the putative 
effectiveness of early circulating plasma TNF-α/IL-10 ratio as an 
important biomarker. In this study, TNF-α/IL-10 ratio was found 
to be highly predictive of hypersusceptibility to infections, with 
high AUROC and high sensitivity and specificity. Our results 
strongly suggest that TNF-α/IL-10 plasma cytokine level, given 
its established role, is a mechanistically feasible biomarker that 
warrants further studies in burn trauma and infections. Since 
the AUROC and/or the sensitivity of the combined model of 
clinical scores with TNF-α/IL-10 was increased compared to 
the clinical model alone, we conclude that TNF-α/IL-10 may 
have some effect independently of injury severity. While our 
study demonstrates the putative usefulness of the TNF-α/IL-10 
ratio in predicting hypersusceptibility to infections in general, 
we did not find strong evidence for specificity toward specific 
pathogen types. It is also possible that differences in pathogens 
were not found due to the complicated nature of polymicrobial 
infections that patients often experience while recovering in the 
hospital. However, since TNF-α and IL-10 are major pro- and 
anti-inflammatory cytokines found to be involved in a variety 
of infections in animal and cell culture models, it is feasible that 
it plays a general role widely, rather than specifically toward 
select pathogens. Considering the ease of harvesting plasma and 
requiring merely two individual cytokine measures, as compared 
to the clinical scores that require multiple measurements over 
time, we suggest that it is important to revalidate our findings 
in other cohorts.
A major limitation of our current study is the relatively low 
number of patients who were eligible to be enrolled in the study 
according to our unique approach that takes into consideration 
the temporality of burn injury, blood collection, and first infec-
tion episode. Future revalidation studies will analyze a larger 
number of patients. However, despite the small size of our study, 
our design using multiple different measures of injury severity 
to assess correlations with TNF-α/IL-10 levels and the biological 
feasibility of our findings in relation to microbial pathogenesis 
gives us confidence in the relevance of our findings. It would also 
be of interest to conduct a study investigating TNF-α/IL-10 levels 
among pediatric burn patients, who may have a different immu-
nological response. Considering our finding that APACHEII, 
a general severity score, was also associated with TNF-α/IL-10 
similarly to TBSA and other burn-specific scores, our results may 
be applicable widely to other modes of severe injury. We therefore 
propose that early plasma TNF-α/IL-10 cytokine ratio may serve 
as a useful, risk predictor for infection hypersusceptibility in 
severe trauma in general.
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